Last reviewed · How we verify
intravenous NAC
intravenous NAC is a Small molecule drug developed by Ochsner Health System. It is currently FDA-approved.
At a glance
| Generic name | intravenous NAC |
|---|---|
| Sponsor | Ochsner Health System |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections: N-Acetylcysteine (PHASE4)
- Evaluation of Differences Between the Standered NAC Regimen Protocol and the SNAP Regimen Protocol in the Treatment of Paracetamol Toxicity for Cases Presented Early and Late to Assiut University Hospitals in Terms of Safety and Efficiecy. (NA)
- Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer (PHASE2)
- Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke (PHASE2)
- Clinical and Molecular Effects of N-Acetylcysteine Treatment in COVID-19-Related Acute Respiratory Distress Syndrome (NA)
- Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial (PHASE2)
- N- Acetylcysteine in Airway Clearance in Broncheictasis (NA)
- Physiological Effects of Nutritional Support in Patients With Parkinson's Disease (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- intravenous NAC CI brief — competitive landscape report
- intravenous NAC updates RSS · CI watch RSS
- Ochsner Health System portfolio CI
Frequently asked questions about intravenous NAC
What is intravenous NAC?
intravenous NAC is a Small molecule drug developed by Ochsner Health System.
Who makes intravenous NAC?
intravenous NAC is developed and marketed by Ochsner Health System (see full Ochsner Health System pipeline at /company/ochsner-health-system).
What development phase is intravenous NAC in?
intravenous NAC is FDA-approved (marketed).
Related
- Manufacturer: Ochsner Health System — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing